Similar articles

• Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States.

  Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H; EUNICE Survival Working Group. Rosso S, et al. Eur J Cancer. 2010 Dec;46(18):3351-7. doi: 10.1016/j.ejca.2010.09.019. Epub 2010 Oct 11. Eur J Cancer. 2010. PMID: 20943375
• [Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality].

  Bonneux LG, Autier P. Bonneux LG, et al. Ned Tijdschr Geneeskd. 2011;155(35):A3774. Ned Tijdschr Geneeskd. 2011. PMID: 21902850 Dutch.
• Screening women at intermediate risk: harm or charm?

  Panizza P, Viganò S, Bonelli L, Bazzocchi M, Belli P, Calabrese M, Caramella D, Corcione S, Del Maschio A, Martincich L, Montemezzi S, Pediconi F, Petrillo A, Sardanelli F, Bruzzi P. Panizza P, et al. Eur J Radiol. 2012 Sep;81 Suppl 1:S116-7. doi: 10.1016/S0720-048X(12)70048-7. Eur J Radiol. 2012. PMID: 23083554 Clinical Trial. No abstract available.
• Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.

  Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group. Njor S, et al. J Med Screen. 2012;19 Suppl 1:33-41. doi: 10.1258/jms.2012.012080. J Med Screen. 2012. PMID: 22972809 Review.
• FPIN’s clinical inquiries. Screening mammography for reducing breast cancer mortality.

  Krishnaiah PB, Nunes NL, Safranek S. Krishnaiah PB, et al. Am Fam Physician. 2012 Jan 15;85(2):176-83. Am Fam Physician. 2012. PMID: 22335218 Review. No abstract available.